Valsartan - Latest Advances

Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study.

Journal: Innovations in pharmacy

Published: October 13, 2025

Postoperative angiotensin II receptor blocker use is associated with reduced 2-year reoperation rates in male patients undergoing arthroscopic rotator cuff repair.

Journal: JSES international

Published: October 06, 2025

Ethics in clinical research: for participant protection and higher-quality research

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 01, 2025

Case 341: Infratentorial Posterior Reversible Encephalopathy Syndrome Associated with Interferon-β in Relapsing Multiple Sclerosis.

Journal: Radiology

Published: September 30, 2025

Targeted antihypertensive therapy after hypertensive pregnancy: Lactation-safe choices, treatment thresholds, and outcomes (2015-2025).

Journal: Current problems in cardiology

Published: September 30, 2025

Pharmacoepigenomic effects of anti-hypertensive drugs on DNA methylation and its implication to drug response and side effects.

Journal: Epigenomics

Published: September 29, 2025

Improving the bioavailability and therapeutic efficacy of valsartan for the control of cardiotoxicity-associated breast cancer.

Journal: Journal of drug targeting

Published: September 20, 2025

Effects of Cardiac Rehabilitation Exercise Plus Sacubitril Valsartan Sodium on Cardiac Function, Lung Function, and Quality of Life in Patients with Chronic Heart Failure.

Journal: Anatolian journal of cardiology

Published: September 19, 2025

Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary Evaluation.

Journal: International journal of pharmaceutical compounding

Published: September 17, 2025

Overlapping Method of Use Patents to Prevent Generic Entry.

Journal: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics

Published: September 16, 2025

Factors associated with the adoption of the WHO Package of Essential Non-Communicable Diseases (PEN) Protocol 1 in primary healthcare settings in Nepal: a cross-sectional study.

Journal: BMJ open

Published: September 11, 2025

Efficacy and safety of sacubitril/valsartan in end-stage renal disease patients with heart failure: a review.

Journal: Annals of medicine

Published: September 09, 2025

Filters

Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study.

Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study.

Postoperative angiotensin II receptor blocker use is associated with reduced 2-year reoperation rates in male patients undergoing arthroscopic rotator cuff repair.

Postoperative angiotensin II receptor blocker use is associated with reduced 2-year reoperation rates in male patients undergoing arthroscopic rotator cuff repair.

Ethics in clinical research: for participant protection and higher-quality research

Ethics in clinical research: for participant protection and higher-quality research

Case 341: Infratentorial Posterior Reversible Encephalopathy Syndrome Associated with Interferon-β in Relapsing Multiple Sclerosis.

Case 341: Infratentorial Posterior Reversible Encephalopathy Syndrome Associated with Interferon-β in Relapsing Multiple Sclerosis.

Targeted antihypertensive therapy after hypertensive pregnancy: Lactation-safe choices, treatment thresholds, and outcomes (2015-2025).

Targeted antihypertensive therapy after hypertensive pregnancy: Lactation-safe choices, treatment thresholds, and outcomes (2015-2025).

Pharmacoepigenomic effects of anti-hypertensive drugs on DNA methylation and its implication to drug response and side effects.

Pharmacoepigenomic effects of anti-hypertensive drugs on DNA methylation and its implication to drug response and side effects.

Improving the bioavailability and therapeutic efficacy of valsartan for the control of cardiotoxicity-associated breast cancer.

Improving the bioavailability and therapeutic efficacy of valsartan for the control of cardiotoxicity-associated breast cancer.

Effects of Cardiac Rehabilitation Exercise Plus Sacubitril Valsartan Sodium on Cardiac Function, Lung Function, and Quality of Life in Patients with Chronic Heart Failure.

Effects of Cardiac Rehabilitation Exercise Plus Sacubitril Valsartan Sodium on Cardiac Function, Lung Function, and Quality of Life in Patients with Chronic Heart Failure.

Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary Evaluation.

Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary Evaluation.

Overlapping Method of Use Patents to Prevent Generic Entry.

Overlapping Method of Use Patents to Prevent Generic Entry.

Factors associated with the adoption of the WHO Package of Essential Non-Communicable Diseases (PEN) Protocol 1 in primary healthcare settings in Nepal: a cross-sectional study.

Factors associated with the adoption of the WHO Package of Essential Non-Communicable Diseases (PEN) Protocol 1 in primary healthcare settings in Nepal: a cross-sectional study.

Efficacy and safety of sacubitril/valsartan in end-stage renal disease patients with heart failure: a review.

Efficacy and safety of sacubitril/valsartan in end-stage renal disease patients with heart failure: a review.